RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Venrock Healthcare Capital Partners
V

Venrock Healthcare Capital Partners portfolio

Venrock Healthcare Capital Partners has 3 portfolio companies on record at Recent Funding, with 2 investments in the last 12 months. It led 2 of the 2 rounds it joined. Its most recent investment on record is CellCentric's $220M Series B+ round in May 2026, which it led, alongside Sofinnova Partners, RA Capital Management, Pfizer and 5 others. By category, its portfolio leans toward Health and bio (3) and Logistics and mobility (1). It has co-invested with Fidelity, RA Capital Management and BrightEdge - American Cancer Society, most often Fidelity (2 rounds).

Type: Investor.
Portfolio on Recent Funding: 3.
Deals, last 12 months: 2.
Rounds led: 2 of 2.
Capital in their rounds: $580M.
Latest deal: CellCentric · May 6, 2026.

What Venrock Healthcare Capital Partners invests in

How Venrock Healthcare Capital Partners invests

StageDealsCapital in rounds
Series B+ 2 100%$580M
YearDealsCapital in rounds
2025 1 50%$360M
2026 1 50%$220M

Share is of the 2 rounds on Recent Funding that name Venrock Healthcare Capital Partners. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Venrock Healthcare Capital Partners portfolio companies

CompanyRound with Venrock Healthcare Capital PartnersTotal raisedLatest raise
CCellCentric
Health and bio
Series B+ · $220M · lead$340MMay 6, 2026
Series B+
TTubulis
Health and bio
Series B+ · $360M · lead$573MOct 16, 2025
Series B+
KKorsana
Health and bio
backer$175MFeb 18, 2026
Series A

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists Venrock Healthcare Capital Partners, which is a subset of its real portfolio. API: /api/v1/investors/venrock-healthcare-capital-partners (get a free API key). More: the most active VC firms and new venture capital funds.

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy